We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Correction: Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells.
- Authors
Li, Hehe; Zhang, Zhengle; Gao, Chenggang; Wu, Shihong; Duan, Qingke; Wu, Heshui; Wang, Chunyou; Shen, Qiang; Yin, Tao
- Abstract
This document is a correction notice for an article titled "Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells." The authors have identified errors in the use and placement of image files in Figures 4 and 5 of the original publication. The corrected figures have been provided in the notice. The publisher, Springer Nature, maintains a neutral stance on jurisdictional claims and institutional affiliations. The authors of the article are Hehe Li, Zhengle Zhang, Chenggang Gao, Shihong Wu, Qingke Duan, Heshui Wu, Chunyou Wang, Qiang Shen, and Tao Yin.
- Subjects
CANCER cell motility; VALPROIC acid; COMBINATION drug therapy; GEMCITABINE
- Publication
Cell & Bioscience, 2023, Vol 13, Issue 1, p1
- ISSN
2045-3701
- Publication type
Correction Notice
- DOI
10.1186/s13578-023-01155-8